General Internal Medicine

Substance Use Disorders

Questions discussed in this category

How do you approach weaning patients off of buprenorphine?

7 Answers available

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

1 Answer available

What approaches have you found most helpful for concurrent severe major depressive disorder and alcohol use disorder?

5 Answers available

Papers discussed in this category

The American journal of psychiatry, 2010-06

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Depression and anxiety, 2013-06

Prospective study of substance-induced and independent major depressive disorder among individuals with substance use disorders in a nationally representative sample.

Journal of addiction medicine, 2021 May-Jun 01

Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.

The American journal on addictions, 2023 Mar 20

Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine.

Related Topics in General Internal Medicine